Literature DB >> 6343337

In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.

M A Miller, M Finan, M Yousuf.   

Abstract

Antagonism of beta-lactam antibiotics by second and third generation cephalosporins was studied in 28 clinical strains of Serratia marcescens and Aeromonas hydrophila. Of the antibiotics tested, both cefoxitin and N-formimidoyl thienamycin (N-f-thienamycin) were capable of antagonism in Ser. marcescens (17 of 20) but in Aerom. hydrophila (7 of 8), only cefoxitin induced antagonism. Antagonism was observed to the greatest degree with cefotaxime and cefoperazone; intermediate with cefamandole and latamoxef (moxalactam) and essentially none with N-f-thienamycin. Inducible beta-lactamase was found in all strains of both genera which exhibited antagonism. The induced beta-lactamase showed enhanced inactivation for other antibiotics in only four strains with none occurring in Aeromonas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343337     DOI: 10.1093/jac/11.4.311

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.

Authors:  E Debbia; P E Varaldo; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 3.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

4.  Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.

Authors:  M A Bertram; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 5.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

6.  Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa.

Authors:  D H Wu; A L Baltch; R P Smith; P E Conley
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

7.  Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

Authors:  E J Kuijper; M F Peeters; B S Schoenmakers; H C Zanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

8.  Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.

Authors:  H Saito; K Sato; B W Jin
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.